Jorge Hernando

1.2k citations
55 papers · 581 indexed · 1 hit paper · h-index 11

Impact in

Papers in

    • Lung Cancer Research Studies 20
    • Pancreatic and Hepatic Oncology Research 11
    • Colorectal Cancer Treatments and Studies 5
    • Colorectal Cancer Surgical Treatments 4
    • Thyroid Cancer Diagnosis and Treatment 11

Jorge Hernando

48 papers receiving 576 citations

Hit Papers

Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial 2021 · 156 citations
156202120262022202450100150

Peers

Jorge Hernando
Comparison fields: 5 of 60
  • Endocrinology, Diabetes and Metabolism 204
  • Oncology 305
  • Neurology 107
  • Epidemiology 159
  • Cancer Research 52
Replace Ying‐Hsia Chu with:
Ying‐Hsia Chu United States
Paola Concolino Italy
Eva Sigstad Norway
Sun Wook Han South Korea
Rebecca Brown United States
Yasuyoshi Sato Japan
Fan Lin United States
Marı́a Niveiro Spain
H. Jouhadi Morocco
Timothy S. Greaves United States
Jorge Hernando relative to Ying‐Hsia Chu United States Ying‐Hsia Chu's profile →
Citations per field
00.5×4.9×
Ying‐Hsia Chu · 1×
Citations per year

Countries citing papers authored by Jorge Hernando

Since Specialization
Citations

This map shows the geographic impact of Jorge Hernando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge Hernando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge Hernando more than expected).

Fields of papers citing papers by Jorge Hernando

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorge Hernando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge Hernando. The network helps show where Jorge Hernando may publish in the future.

Co-authors

The 25 scholars most cited alongside Jorge Hernando, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jorge Hernando Line = papers co-authored together Jorge Hernando links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial
Hit paper breakdown →
2021156
2 202097
3 201848
4 201928
5 202225
6 202023
7 202221
8 202116
9 201816
10 202215
11 201910
12 202410
13 202210
14 20238
15 20198
16 20208
17 20217
18 20236
19 20235
20 20205

About Jorge Hernando

Jorge Hernando is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism, Neurology, Epidemiology and Cancer Research, having authored 55 papers that have together received 581 indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (25 papers), Lung Cancer Research Studies (20 papers), Pancreatic and Hepatic Oncology Research (11 papers), Thyroid Cancer Diagnosis and Treatment (11 papers), Neuroblastoma Research and Treatments (11 papers), Colorectal Cancer Treatments and Studies (5 papers), Colorectal Cancer Surgical Treatments (4 papers) and Cancer Genomics and Diagnostics (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (204 citations), Oncology (305 citations), Neurology (107 citations), Epidemiology (159 citations) and Cancer Research (52 citations). Jorge Hernando has collaborated with scholars based in Spain, Palestinian Territory and United States. Frequent co-authors include Jaume Capdevila, Jaume Capdevila, Marcia S. Brose, Josep Tabernero, Jennifer Oliver, Steven I. Sherman, Ana O. Hoff, Jolanta Krajewska, Fernanda Vaisman and Bruce Robinson. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, The Oncologist, Clinical Cancer Research and Clinical & Translational Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026